GW Vitek CO.,LTD. (KOSDAQ:036180)

Market Cap	186.93M -99.7%
Revenue (ttm)	15.77B -60.3%
Net Income	-6.45B
EPS	-69.30
Shares Out	93.46M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	46,865,770
Average Volume	29,514,578
Open	4.000
Previous Close	5.000
Day's Range	2.000 - 4.000
52-Week Range	2.000 - 36.000
Beta	0.84
RSI	n/a
Earnings Date	Nov 14, 2025

About GW Vitek CO.,LTD.

GW Vitek CO.,LTD., together with its subsidiaries, engages in the development, manufacturing, and sale of bio-related antibodies and biotechnology solutions in Korea, the United States, Asia, Europe, and internationally. It is also involved in supply of scientific equipment and related consumables; and provision of technology services. The company was formerly known as A-Frontier Co.,Ltd. and changed its name to GW Vitek CO.,LTD. in December 2020. GW Vitek CO.,LTD. was founded in 1994 and is headquartered in Seoul, South Korea.

• Industry: Radio and Television Broadcasting and Communications Equipment
• Founded: 1994
• Employees: 29
• Stock Exchange: KOSDAQ
• Ticker Symbol: 036180

Financial Performance

In 2024, GW Vitek CO.,LTD.'s revenue was 28.07 billion, a decrease of -41.42% compared to the previous year's 47.92 billion. Losses were -12.25 billion, -17.94% less than in 2023.